BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ricart E, García-Bosch O, Ordás I, Panés J. Are we giving biologics too late? The case for early versus late use. World J Gastroenterol 2008; 14(36): 5523-5527 [PMID: 18810770 DOI: 10.3748/wjg.14.5523]
URL: https://www.wjgnet.com/1007-9327/full/v14/i36/5523.htm
Number Citing Articles
1
Alain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, Ekaterina Safroneeva, Alex Straumann, Valérie Pittet, Laurent Peyrin-Biroulet, Pierre Michetti, Gerhard Rogler, Stephan R Vavricka. Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation RateAmerican Journal of Gastroenterology 2013; 108(11): 1744 doi: 10.1038/ajg.2013.248
2
Salvador Pous-Serrano, Matteo Frasson, Jose Pàmies-Guilabert, Polina Rudenko, Icíar Puchades-Roman, Belén Beltrán, Pilar Nos Mateu, Eduardo García-Granero. Use of Magnetic Resonance Index of Activity (MaRIA) in the Preoperative Assessment of Small Bowel Crohn’s DiseaseCirugía Española (English Edition) 2019; 97(10): 582 doi: 10.1016/j.cireng.2019.11.006
3
Jacob Tveiten Bjerrum, Yulan Wang, Fuhua Hao, Mehmet Coskun, Christian Ludwig, Ulrich Günther, Ole Haagen Nielsen. Metabonomics of human fecal extracts characterize ulcerative colitis, Crohn’s disease and healthy individualsMetabolomics 2015; 11(1): 122 doi: 10.1007/s11306-014-0677-3
4
Elizabeth A. Scoville, Margaret M. Allaman, Caroline T. Brown, Amy K. Motley, Sara N. Horst, Christopher S. Williams, Tatsuki Koyama, Zhiguo Zhao, Dawn W. Adams, Dawn B. Beaulieu, David A. Schwartz, Keith T. Wilson, Lori A. Coburn. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profilingMetabolomics 2018; 14(1) doi: 10.1007/s11306-017-1311-y
5
Michele Carvello, Silvio Danese, Antonino Spinelli. Surgery versus Medical Therapy in Luminal Ileocecal Crohn's DiseaseClinics in Colon and Rectal Surgery 2022; 35(01): 072 doi: 10.1055/s-0041-1740031
6
José Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, María Chaparro, Pilar López Serrano, Manuel Van Domselaar, Fernando Bermejo, Ramón Pajares, Ángel Ponferrada, María Isabel Vera, Pilar Martínez Montiel, Javier P. Gisbert, José Luis Pérez-Calle, Antonio López San Román, Luis Abreu, Luis Alberto Menchén, Ignacio Marín-Jiménez. Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experienceGastroenterología y Hepatología 2011; 34(7): 443 doi: 10.1016/j.gastrohep.2011.04.001
7
Matteo Frasson, Luis Sendra, Antonio Miguel, Maria José Herrero, Eva Montalvá, Rafael López-Andújar, Juan Martínez-Pastor, Luis Martí-Bonmatí, Eduardo García Granero, Salvador Aliño. Hydrodynamic IL10 Gene Transfer in Human ColonInflammatory Bowel Diseases 2017; 23(8): 1360 doi: 10.1097/MIB.0000000000001197
8
Salvador Pous-Serrano, Matteo Frasson, José Pàmies-Guilabert, Polina Rudenko, Icíar Puchades-Román, Belén Beltrán, Pilar Nos Mateu, Eduardo García-Granero. La resonancia magnética y el índice MaRIA en la valoración preoperatoria de la enfermedad de Crohn ilealCirugía Española 2019; 97(10): 582 doi: 10.1016/j.ciresp.2019.06.018
9
Jeffrey W. Molloy, Joel Z. Stengel, Hays L. Arnold. Infliximab: A Review of its Use in the Treatment of Crohn's DiseaseClinical Medicine. Therapeutics 2009; 1: CMT.S2250 doi: 10.4137/CMT.S2250
10
Naoto Saigusa, Tadashi Yokoyama, Masaru Shinozaki, Ryoji Miyahara, Tsuyoshi Konishi, Toshio Nakamura, Yasuhisa Yokoyama. Anorectal fistula is an early manifestation of Crohn’s disease that occurs before bowel lesions advance: a study of 11 casesClinical Journal of Gastroenterology 2013; 6(4): 309 doi: 10.1007/s12328-013-0404-z
11
Ho Suk Kang, Ja Seol Koo, Kang Moon Lee, Dae Bum Kim, Ji Min Lee, Yoon Jae Kim, Hyuk Yoon, Hyun Joo Jang. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha useWorld Journal of Gastroenterology 2019; 25(8): 989-1001 doi: 10.3748/wjg.v25.i8.989
12
Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort StudyJournal of Crohn's and Colitis 2019; 13(10): 1292 doi: 10.1093/ecco-jcc/jjz057
13
Arkady Broder, Joel R. Rosh. Infliximab: A Review of its use in the Treatment of Pediatric Crohn's DiseaseClinical Medicine Insights: Therapeutics 2010; 2: CMT.S2840 doi: 10.4137/CMT.S2840
14
Giovanni Latella, Renzo Caprilli, Simon Travis. In favour of early surgery in Crohn's disease: A hypothesis to be testedJournal of Crohn's and Colitis 2011; 5(1): 1 doi: 10.1016/j.crohns.2010.11.003
15
Stephan R. Vavricka, Sabrina M. Spigaglia, Gerhard Rogler, Valérie Pittet, Pierre Michetti, Christian Felley, Christian Mottet, Christian P. Braegger, Daniela Rogler, Alex Straumann, Peter Bauerfeind, Michael Fried, Alain M. Schoepfer. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel diseaseInflammatory Bowel Diseases 2012; 18(3): 496 doi: 10.1002/ibd.21719
16
Marco Gasparetto, Graziella Guariso. Crohn's disease and growth deficiency in children and adolescentsWorld Journal of Gastroenterology 2014; 20(37): 13219-13233 doi: 10.3748/wjg.v20.i37.13219
17
Manuel Barreiro-de Acosta, Aurelio Lorenzo, Jose Mera, J. Enrique Dominguez-Muñoz. Mucosal healing and steroid-sparing associated with infliximab for steroid-dependent ulcerative colitisJournal of Crohn's and Colitis 2009; 3(4): 271 doi: 10.1016/j.crohns.2009.06.003
18
Laila El Shabrawi-Caelen, Michelangelo La Placa, Colombina Vincenzi, Thomas Haidn, Robert Muellegger, Antonella Tosti. Adalimumab-induced psoriasis of the scalp with diffuse alopecia: A severe potentially irreversible cutaneous side effect of TNF-alpha blockersInflammatory Bowel Diseases 2010; 16(2): 182 doi: 10.1002/ibd.20954